SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
enGene Holdings Inc. (ENGN) has a negative trailing P/E of -3.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 5.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -25.48%, forward earnings yield 16.86%.
Criteria proven by this page:
- VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 5.9 — analysts expect a return to profitability with estimated EPS of $1.31 for FY2030.
- Trailing Earnings Yield -25.48% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 16.86% as earnings recover.
- Analyst consensus target $24.60 (+217% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 45/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ENGN
Valuation Multiples
P/E (TTM)-3.9
Forward P/E5.9
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.71
P/S Ratio0.00
EV/EBITDA-3.1
Per Share Data
EPS (TTM)$-1.82
Forward EPS (Est.)$1.31
Book Value / Share$4.19
Revenue / Share$0.00
FCF / Share$-1.54
Yields & Fair Value
Earnings Yield-25.48%
Forward Earnings Yield16.86%
Dividend Yield0.00%
Analyst Target$24.60 (+217%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2020 |
-21.0 |
0.00 |
0.00 |
0.00 |
- |
| 2021 |
-13.5 |
0.14 |
2.48 |
0.00 |
- |
| 2022 |
-12.9 |
0.11 |
2.48 |
0.00 |
- |
| 2023 |
-4.7 |
0.00 |
6.50 |
0.00 |
- |
| 2024 |
-7.2 |
0.11 |
1.45 |
0.00 |
- |
| 2025 |
-3.1 |
-0.06 |
2.20 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$-0.95 |
$0.00 |
$-15.07M |
- |
| 2021 |
$-1.48 |
$0.00 |
$-23.44M |
- |
| 2022 |
$-1.55 |
$0.00 |
$-24.46M |
- |
| 2023 |
$-4.24 |
$0.00 |
$-99.92M |
- |
| 2024 |
$0.15 |
$0.00 |
$55.14M |
- |
| 2025 |
$-2.29 |
$0.00 |
$-117.3M |
- |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-1.99 |
$-2.17 – $-1.77 |
$4.78M |
$1.69M – $15.81M |
8 |
| 2027 |
$-1.96 |
$-2.66 – $-1.15 |
$23.81M |
$7.55M – $70.66M |
7 |
| 2028 |
$-1.47 |
$-5.86 – $-0.23 |
$101.12M |
$35.71M – $334.36M |
3 |
| 2029 |
$-0.51 |
$-2.04 – $-0.08 |
$243.27M |
$85.92M – $804.37M |
4 |
| 2030 |
$1.31 |
$0.21 – $5.23 |
$449.36M |
$158.7M – $1.49B |
2 |
